找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 20203rd edition The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr

[復(fù)制鏈接]
查看: 49017|回復(fù): 59
樓主
發(fā)表于 2025-3-21 19:36:52 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Immunotherapy
編輯Aung Naing,Joud Hajjar
視頻videohttp://file.papertrans.cn/463/462295/462295.mp4
概述Highlights recent updates in immunotherapeutic strategies to treat patients with solid tumors.Informs on the spectrum of immune-related adverse events.Outlines strategies to overcome challenges associ
叢書名稱Advances in Experimental Medicine and Biology
圖書封面Titlebook: Immunotherapy;  Aung Naing,Joud Hajjar Book 20203rd edition The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr
描述.Immunotherapy is a rapidly evolving field that mandates frequent revision of the book as new insights to fight cancer emerge. The third edition of?.Immunotherapy.?is an updated overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. It explores the breath of immunotherapeutic strategies available to treat a wide range of cancers, from melanoma and non-small cell lung cancer to gastrointestinal, genitourinary, gynecologic and nervous system malignancies. With increasing use of checkpoint inhibitors as standard of care and in clinical trials, the challenges associated with their use undoubtedly increase. As objective response is limited to a subset of patients and is often associated with distinct immune related side effects that are potentially life threatening, it is essential to identify patients who are likely to respond to immunotherapy and those who are at a risk for developing treatment-related side effects. In the absence of a validated predictive biomarker, innovative technologies and assays are being used to identify critical biomarkers that drive the immune response. Hence, a chapter to provide a basic understanding of the diagn
出版日期Book 20203rd edition
關(guān)鍵詞translational cancer immunology; vaccine; il-10; immune-oncology; tumor immunology; immune-therapy; immune
版次3
doihttps://doi.org/10.1007/978-3-030-41008-7
isbn_ebook978-3-030-41008-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Immunotherapy影響因子(影響力)




書目名稱Immunotherapy影響因子(影響力)學(xué)科排名




書目名稱Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Immunotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Immunotherapy被引頻次




書目名稱Immunotherapy被引頻次學(xué)科排名




書目名稱Immunotherapy年度引用




書目名稱Immunotherapy年度引用學(xué)科排名




書目名稱Immunotherapy讀者反饋




書目名稱Immunotherapy讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:27:34 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:09:31 | 只看該作者
地板
發(fā)表于 2025-3-22 04:55:56 | 只看該作者
5#
發(fā)表于 2025-3-22 11:03:56 | 只看該作者
6#
發(fā)表于 2025-3-22 15:58:11 | 只看該作者
7#
發(fā)表于 2025-3-22 20:15:45 | 只看該作者
8#
發(fā)表于 2025-3-22 21:48:43 | 只看該作者
9#
發(fā)表于 2025-3-23 04:01:14 | 只看該作者
Mingxuan Xu,Ilgin Ergin,Semir Beyazre. ” In the 1960s and subsequent decades, the clinical During life, there exist phases of age-related c- and immunological aspects of immune deficiencies were promised immune functions. After birth there is a phys- studied and adequate treatment attempted. A reflection of logical immune deficiency because th978-0-306-47527-6
10#
發(fā)表于 2025-3-23 05:52:48 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-7 05:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
嘉鱼县| 民勤县| 金阳县| 美姑县| 平利县| 措美县| 油尖旺区| 进贤县| 马龙县| 德令哈市| 桦甸市| 瓦房店市| 平湖市| 油尖旺区| 海盐县| 德格县| 安庆市| 天祝| 江口县| 潼南县| 政和县| 河曲县| 五常市| 高雄市| 浏阳市| 淮北市| 驻马店市| 沧州市| 洛阳市| 措勤县| 密云县| 郸城县| 若尔盖县| 武清区| 长沙县| 巴南区| 民县| 焉耆| 饶阳县| 高阳县| 上高县|